Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ: PCSA · Real-Time Price · USD

0.278

+0.007 (2.51%)

At close: Dec 5, 2025, 4:00 PM EST

0.270

-0.008 (-2.88%)

After-hours: Dec 5, 2025, 7:34 PM EST

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $15.75 million. The enterprise value is $9.44 million.

Market Cap	15.75M
Enterprise Value	9.44M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PCSA has 56.64 million shares outstanding. The number of shares has increased by 669.63% in one year.

Current Share Class	56.64M
Shares Outstanding	56.64M
Shares Change (YoY)	+669.63%
Shares Change (QoQ)	+205.25%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	17.46%
Float	51.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.52
P/TBV Ratio	2.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.76

Current Ratio	3.76
Quick Ratio	3.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -270.74% and return on invested capital (ROIC) is -168.65%.

Return on Equity (ROE)	-270.74%
Return on Assets (ROA)	-129.94%
Return on Invested Capital (ROIC)	-168.65%
Return on Capital Employed (ROCE)	-223.21%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.61% in the last 52 weeks. The beta is 1.09, so PCSA's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-72.61%
50-Day Moving Average	0.31
200-Day Moving Average	0.29
Relative Strength Index (RSI)	48.29
Average Volume (20 Days)	1,308,730

Short Selling Information

The latest short interest is 5.36 million, so 9.46% of the outstanding shares have been sold short.

Short Interest	5.36M
Short Previous Month	9.05M
Short % of Shares Out	9.46%
Short % of Float	10.50%
Short Ratio (days to cover)	1.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.02M
Pretax Income	-12.93M
Net Income	-12.93M
EBITDA	-13.02M
EBIT	-13.02M
Earnings Per Share (EPS)	-$0.66

Full Income Statement

Balance Sheet

The company has $6.31 million in cash and n/a in debt, giving a net cash position of $6.31 million or $0.11 per share.

Cash & Cash Equivalents	6.31M
Total Debt	n/a
Net Cash	6.31M
Net Cash Per Share	$0.11
Equity (Book Value)	5.83M
Book Value Per Share	0.11
Working Capital	4.84M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.73M
Capital Expenditures	n/a
Free Cash Flow	-10.73M
FCF Per Share	-$0.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-669.63%
Shareholder Yield	-669.63%
Earnings Yield	-82.13%
FCF Yield	-68.15%

Analyst Forecast

The average price target for PCSA is $1.00, which is 259.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$1.00
Price Target Difference	259.71%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1